Latest Posts
About This Stock
More About This Stock
Read
Read
Allergan Acquires Kythera Bio For $2.1 Billion
Article By:
Terry Chrisomalis
Wednesday, June 17, 2015 7:59 AM EDT
Allergan announced today that it will buy Kythera Bio for $2.1 billion or $75 per share as a cash and equity type deal.
PFNX In Development Pact For Macular Degeneration Drug; KYTH Acquires Worldwide Rights To Potential Novel Treatment Of Hair Loss
Article By:
BioMedReports
Wednesday, February 11, 2015 7:05 AM EDT
Pfenex Inc. In Development Pact For Macular Degeneration Drug, KYTHERA Acquires Worldwide Rights to Potential Novel Treatment of Hair Loss
Amgen Gets FDA Panel Backing For Melanoma Vaccine T-VEC
Great article as usual Terry. What's your take on the recent news on $KYTH?
www.cnn.com/.../index.html